Prediction Case File
YouTubeEvaluation Complete

Is Affirm Stock an Undervalued Stock to Buy? | AFRM STock Analysis

1 extracted signal · 0 resolved · 0 still active

Parkev Tatevosian, CFA profile imageParkev Tatevosian, CFAIndependent analyst profile
Source published
18 May 2026, 14:45 UTC
Recorded by Tahlil Plus
19 May 2026, 02:24 UTC
Video preview for Is Affirm Stock an Undervalued Stock to Buy? | AFRM STock Analysis
Source overview

AI-generated source summary

Affirm's consumer health remains strong, with no observed change in demand or ability to repay. Delinquencies are in line with expectations, driven partly by a reduced tax refund seasonality. Strong unit economics are noted, with the company capturing demand that delivered great returns. Credit continues to be a focus. Zesty capital markets demand reflects confidence in their approach to credit. The company increased capacity despite lower seasonal volume, and priced its third consecutive revolving ABS transaction at a favorable yield. Average annualized cost of funds reached a three-and-a-half-year low. The company has seen significant growth in active consumers and active merchants, increasing by 44% to 515,000. Active consumers grew 22% to 26.8 million. The valuation appears attractive, with a forward price-to-earnings ratio of 16.34 and a forward price-to-free cash flow ratio of 12.25, suggesting a potentially undervalued stock for investors with a higher risk tolerance.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
1
Cancelled, invalid or excluded
Resolved success
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  7. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Analyst snapshot

Parkev Tatevosian, CFA

Platform-wide history, separate from this source evaluation.

Reliability
40.9
Tracked signals
1239
Historical success
24.5%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail